Jennifer Van Eyk, PhD

Jenny is a recognized international leader in clinical proteomics. Under her direction, compelling biological questions meet innovative proteomic analytical techniques to help address clinically meaningful problems.

Jenny is focused on developing technical pipelines for de novo discovery and larger scale quantitative mass spectrometry methods. This includes multiple reaction monitoring (MRM, also known as SRM) and most recently data-independent acquisition. 

Her lab at Cedars-Sinai Medical Center is well known for the extreme technical quality of the data generated and for rigorous quality control with tight %CV, while applying these to key clinical questions. The aim is to maximize throughput and reproducibility in order to move targeted and robust discovery methods into large populations, paving the way for healthy continuous assessment and clinical grade assays focusing on brain and cardiovascular diseases.